News

Lilly and Novo

In a major development, pharmaceutical giants Eli Lilly and Novo Nordisk are reportedly close to finalising a deal with the Trump administration …

Kimberly-Clark Kenvue Deal

In one of the biggest consumer health acquisitions, Kimberly-Clark, the maker of Huggies, Kleenex, and Kotex, is set to acquire Kenvue, the …

FDA Official Resigns

The FDA official resigns amid concerns about the agency’s leadership and approval processes.  It was also during an ethics investigation and a …

Unsafe Baby Scan Clinics

A new wave of concern has swept through the UK’s maternity sector after experts warned that unsafe baby scan clinics, unregulated private …

Bacteria in Baby Formula

A new study has sounded an alarm for parents and public health experts alike, even when prepared following all safety guidelines, baby …

Online Brain Training

In a groundbreaking study from McGill University, scientists discovered that a digital online brain training program could reverse up to 10 years …

New 3D Bioprinter

In a remarkable breakthrough, researchers have created a new 3D Bioprinter, the world’s smallest, just 2.7 millimetres wide, about the size of …

FDA’s Guidelines For Copycat Drugs

In a move that could reshape the prescription drug landscape, the U.S. Food and Drug Administration (FDA) has announced plans to speed …

New Drug for Menopause

The FDA’s approval of a new drug for menopause, Elinzanetant (brand name Lynkuet), is making global headlines for being the second non-hormonal …

Queensland Puberty Blocker Ban

In a fast-moving series of events, the Queensland puberty blocker ban has been restored. It creates the need to discuss about the …

Open AI’s New-Pharma-Deals

OpenAI’s new pharma deals with Thermo Fisher Scientific and Lundbeck were recently announced. These collaborations mark a turning point in how artificial …

3D Printed Face

A 75-year-old cyclist, Peter Maggs, received a new 3D-printed face after facial trauma in a devastating drink-driving crash. Using advanced digital imaging …

Scroll to Top